Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Merz

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Arzneimittel-Forschung|January 1, 1992
[Biological availability and pharmacodynamics following single oral administration or three different sustained-release isosorbide-5-mononitrate dosage forms]P G Merz, P Thürmann, S Harder
Arzneimittel-Forschung|July 1, 1991
[Biologic availability and hemodynamic actions following administration of sublingual glycerol trinitrate. A new delivery system]T Huber, P G Merz, S Harder
Arzneimittel-Forschung|December 1, 1990
Bioaequivalence of sublingual glycerol trinitrate. Bioavailability and haemodynamic effects after application of a fluorochlorohydrocarbons-dependent spray and a new pumping systemT Huber, P G Merz, S Harder, et al.
Deutsche Medizinische Wochenschrift (1946)|November 22, 1985
[Bioavailability of isosorbide dinitrate and isosorbide-5-mononitrate under steady-state conditions]N Rietbrock, J Knoll, P G Merz, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Lack of a pharmacokinetic interaction between carvedilol and digitoxin or phenprocoumonS Harder, R Brei, S Caspary, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1991
Pharmacokinetics of nicotine after application of a 30 cm2 nicotine patch under steady-state conditionsS Caspary, B Keller-Stanislawski, T Huber, et al.
Arzneimittel-Forschung|July 1, 1993
Steady state kinetics of a fatty alcohol-based slow-release nifedipine for once a day applicationB G Woodcock, P G Merz, S Rietbrock, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1996
Differences in the nyctohemeral secretion of TSH and PRL in healthy euthyroid menJ S Dericks-Tan, P G Merz, A Schrödter, et al.
European Journal of Rheumatology and Inflammation|January 1, 1993
Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in manB G Woodcock, D Acerbi, P G Merz, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1993
Transdermal nicotine in smoking cessation and involvement of non-specific influencesP G Merz, B Keller-Stanislawski, T Huber, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Arzneimittel-Forschung|January 1, 1992
[Biological availability and pharmacodynamics following single oral administration or three different sustained-release isosorbide-5-mononitrate dosage forms]P G Merz, P Thürmann, S Harder
Arzneimittel-Forschung|July 1, 1991
[Biologic availability and hemodynamic actions following administration of sublingual glycerol trinitrate. A new delivery system]T Huber, P G Merz, S Harder
Arzneimittel-Forschung|December 1, 1990
Bioaequivalence of sublingual glycerol trinitrate. Bioavailability and haemodynamic effects after application of a fluorochlorohydrocarbons-dependent spray and a new pumping systemT Huber, P G Merz, S Harder, et al.
Deutsche Medizinische Wochenschrift (1946)|November 22, 1985
[Bioavailability of isosorbide dinitrate and isosorbide-5-mononitrate under steady-state conditions]N Rietbrock, J Knoll, P G Merz, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Lack of a pharmacokinetic interaction between carvedilol and digitoxin or phenprocoumonS Harder, R Brei, S Caspary, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1991
Pharmacokinetics of nicotine after application of a 30 cm2 nicotine patch under steady-state conditionsS Caspary, B Keller-Stanislawski, T Huber, et al.
Arzneimittel-Forschung|July 1, 1993
Steady state kinetics of a fatty alcohol-based slow-release nifedipine for once a day applicationB G Woodcock, P G Merz, S Rietbrock, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1996
Differences in the nyctohemeral secretion of TSH and PRL in healthy euthyroid menJ S Dericks-Tan, P G Merz, A Schrödter, et al.
European Journal of Rheumatology and Inflammation|January 1, 1993
Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in manB G Woodcock, D Acerbi, P G Merz, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1993
Transdermal nicotine in smoking cessation and involvement of non-specific influencesP G Merz, B Keller-Stanislawski, T Huber, et al.
Pageof 2